BioCentury | May 13, 2002
Company News
Bioption AB, International AIDS Vaccine Initiative deal
Bioption partnered with the initiative to develop an HIV/AIDS vaccine. The initiative will finance and coordinate research based on SFV alphavirus replicon technology from the Karolinska Institute (Stockholm, Sweden). Bioption AB , Stockholm, Sweden International AIDS...